MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS

Clinical trials for MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS trials appear

Sign up with your email to follow new studies for MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for fighting tough tuberculosis strains

Disease control Recruiting now

This study is testing a new drug, JDB0131, combined with other medicines to treat tuberculosis that is resistant to standard antibiotics. It will involve 60 patients with this hard-to-treat form of TB to see if the new combination is effective and safe over 8 weeks. The main goal…

Matched conditions: MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS

Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS

Get alerted when new MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS trials appear

New hope for fighting tough tuberculosis strains